VEGF isoforms and mutations in human colorectal cancer

International Journal of Cancer

Volumn 101, Issue 1, 2002, Pages 32-36

  Uthoff, Sonja M S ^a,b   Duchrow, Michael ^a   Schmidt, Mirko H H ^a   Broll, Rainer ^a   Bruch, Hans Peter ^a   Strik, Martin W ^a   Galandiuk, Susan ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b University of Louisville School of Medicine   (United States)

Author keywords

Angiogenesis; Sporadic colon and rectal cancer; Vascular endothelial growth factor (VEGF); VEGF isoforms; VEGF mutants; VEGF145

Indexed keywords

RNA; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DNA POLYMORPHISM; EXON; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN CONFORMATION; RNA EXTRACTION; RNA SPLICING; SOLID TUMOR;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION PROFILING; HUMANS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036722934     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10552     Document Type: Article

References (34)

1. Tumor angiogenesis: Therapeutic implications
2. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
3. Vascular endothelial growth factor is a secreted angiogenic mitogen
4. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
5. Vascular endothelial growth factor (VEGF) and its receptors
6. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
7. Vascular permeability factor (VPF, VEGF) in tumor biology
8. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
9. Vascular endothelial growth factor. From basic research to clinical application
10. Targetting VEGF in anti-angiogenic and anti-tumour therapy: Where are we now?
11. Vascular endothelial growth factor: Regulation by cell differentiation and activated second messenger pathways
12. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
13. Hypoxia regulatory elements of the human vascular endothelial growth factor gene
14. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
15. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
16. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
17. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
18. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro
19. Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
20. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively
21. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
22. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
23. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
24. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
25. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
26. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extra-cellular matrix and bioactivity of extracellular matrix-bound VEGF
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes
29. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
30. Genetic regulation of cytokine synthesis: Consequences for acute and chronic organ allograft rejection
31. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene
32. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels
33. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production
34. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation